Ticker HubNasdaq

ARQT

Arcutis Biotherapeutics, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS

Latest price

$31.69+1.57%

As of Oct 26, 2026, 7:01 PM EDT · Market data by Massive

Market cap

$3.9B

Volume

1.5M

Previous close

$31.20

Day range

$31.35 – $32.26

Listed

Jan 31, 2020

Coverage

1 article

Price performance

Recent trading

5 trading days · 15-minute intervals · ET

Five-day open $32.09Latest interval $31.69

Newsroom

Latest ARQT coverage

BiotechBusinessFeb 20, 2025

Arcutis Biotherapeutics Surges Amid Takeover Speculation: Why Large Pharma Should Pay Attention!

According to a Betaville "uncooked" alert, an unidentified European pharmaceutical company is reportedly exploring a bid for Arcutis Biotherapeutics.

ARQTABBVSNYLLY

Company overview

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Industry: PHARMACEUTICAL PREPARATIONS
Employees: 354
Headquarters: WESTLAKE VILLAGE, CA
CIK: 0001787306

Company website View advanced chart

SEC filings

No filing records are attached to this profile yet.

Browse EDGAR

Profile at a glance

Jan 31, 2020

Listed

354

Employees

Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.